Stock·NASDAQ·Consumer Defensive
Celsius Holdings Inc. (CELH)
- Market cap
- $7.08B
- Dividend yield
- None
- Street target
- $40.00median of 24 analysts
- 52-week range
- $23.56 $62.55
CELH stock forecast today
Where CELH stands today, and what CleaRank Financial AI makes of it.
CELH at a glance
Celsius Holdings Inc. (CELH): Hold, 41/100 on CleaRank's AI score.
- Trend Down: the price is below both its 50- and 200-day moving averages ($29.32 and $34.89).
- Earnings CELH beat estimates in 4 of the 6 reports in our data, yet fell the next day after 2 of those beats.
- Insiders Insiders sold $51.3M and bought $3.2M over the last 18 months.
Figures as of October 27, 2026.
CleaRank Financial AI
CleaRank rates Celsius Holdings Inc. (CELH) Hold, with a model score of 41/100.
The analysts' outlook lifts the score most: 18 of 24 analysts rate it a buy and the median target is 42.9% above the price. The trend holds it back most: the price is 19.75% below its 200-day average and 4.49% below its 50-day average, and the 50-day average is 15.97% below the 200-day. The 50-day average stands at $29.32 and the 200-day at $34.89. Over the past year the price fell 55.00%.
Only on CleaRank
Figures we compute ourselves from CELH's own price, earnings and insider-filing history. Tap one to see it in context.
CELH stock price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
0/4Price above its 50-day average ›
The price of $28.00 is 4.5% below the 50-day simple moving average of $29.32.Price above its 200-day average ›
The price is 19.7% below the 200-day simple moving average of $34.89.50-day average above the 200-day ›
The 50-day average ($29.32) is 16.0% below the 200-day average ($34.89), the arrangement of a falling longer-term trend.In the upper half of its 52-week range ›
The price sits at 11% of its 52-week range, between $23.56 and $62.55.
CELH share price
Pick a period: each tab shows how far CELH has moved over it, to the last close.
Today's trading
Where CELH sits inside today's range and its 52-week range.
CELH fundamentals and valuation
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
2/3P/S below the sector median ›
The price-to-sales ratio of 2.33 is 5.7% above the sector median of 2.2.Profitable over the last 12 months ›
Net income over the last 12 months was $129.1M on revenue of $3.0B, a net margin of 4.2%.Beat estimates in most recent reports ›
CELH beat the EPS estimate in 4 of the 6 reports in our data.
Key statistics
The headline figures for CELH.
As of October 27, 2026, CELH trades at $28.00, with a market value of $7.08B.
What the numbers say
CleaRank Financial AI's reading of CELH's valuation, growth and risks.
On sales, the price-to-sales ratio of 2.33 is 5.9% above the sector median of 2.2. To put the company in size terms, its market capitalisation is $7.1B.
Growth outpaces the sector: revenue grew 10.60% in the latest quarter year on year, against a sector median of 5.3%. Profitability shows a net margin of 4.24% and an operating margin of 19.09%, with a return on equity of 5.11%, below the sector median of 19.7%. Rounding out the fundamentals, CELH reports debt-to-equity of 0.23.
CELH reported its latest quarter on August 6, 2026, and EPS of $0.36 fell short of the $0.42 estimate, so the company missed the estimate by 14.29%. Even so, the share price climbed 16.83% in the following session.
CELH beat the EPS estimate in 4 of the 6 reports in our data, but beats have not guaranteed gains: the stock fell the next day after 2 of them. The November 6, 2025 report stands out among the few before the latest: a beat of 50.00%, after which the stock fell 7.86%. Analysts' average EPS estimate for this fiscal year is $1.42, which would be growth of 5.9%, and $1.70 for next year (growth of 19.8%).
Typical daily moves for the stock are around 2.36%, and its beta against the S&P 500 is 1.00. Until the price gets back above its moving averages, the trend is a headwind for holders. The shares are also 55.24% below the 52-week high of $62.55.
CELH against the Consumer Defensive sector
How CELH compares with the median Consumer Defensive stock CleaRank tracks.
Price to sales vs sector: On price-to-sales, the yardstick used here in place of P/E, CELH trades at 2.33x, +6% versus the sector average of 2.20x.
Return vs SPY: Since May 15, 2025, CELH has lost 28.3% against a gain of 30.4% for SPY.
Performance against SPY
CELH and the S&P 500 (SPY) over the same days.
Revenue and earnings
How much CELH sells, and how much of it becomes profit.
Revenue growth: Revenue grew 85.5% in FY2025 to $2.5B, from $1.4B a year earlier.
Profit margin: The net margin was 4.3% in FY2025, down from 10.7% the year before.
Profitable: CELH earned $108M in FY2025.
Earnings reality check
Did CELH beat what analysts expected, and how did the stock react?
Earnings record: CELH beat the analyst estimate in 4 of the 6 reports in our data.
Market reaction: The stock fell in the first session after 2 of those 4 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Aug 6, 2026after close | $0.42 | $0.36 | -14.29% | +16.83% | +21.08% |
| Feb 26, 2026after close | $0.19 | $0.26 | +36.84% | -0.94% | -19.27% |
| Nov 6, 2025after close | $0.28 | $0.42 | +50.00% | -7.86% | -2.33% |
| Aug 7, 2025after close | $0.24 | $0.47 | +95.83% | +3.65% | +13.07% |
| May 6, 2025after close | $0.19 | $0.18 | -5.26% | +0.76% | +6.78% |
| Feb 20, 2025after close | $0.10 | $0.14 | +40.00% | +27.77% | +1.80% |
As of October 27, 2026, CELH has beaten the analyst EPS estimate in 4 of the 6 reports in our data and fell in the first trading session after 2 of those beats; its latest report, on August 6, 2026, came in 14.29% below the estimate and the stock moved +16.83% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
CELH AI analysis and technical indicators
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 47.3, in neutral territory.RSI above 50 ›
An RSI of 47.3 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank Financial AI analysis of CELH
The score, the reasoning behind it, and what could move the price next.
CELH is trading in a downtrend. At $28.00, the stock sits 4.49% below its 50-day average of $29.32 and 19.75% below its 200-day average of $34.89. Its price is close to the floor of its 52-week range: it is 18.85% above the low of $23.56, while 55.24% below the high of $62.55. The 50-day average is 15.97% below the 200-day, a gap that backs up the weak trend instead of cutting against it.
Recent gains sit against a weaker longer record: the price rose 0.04% over the past month, fell 4.92% over the past three months and fell 55.00% over the past year. The 14-day RSI of 47.3 is in the neutral zone, and the MACD line is negative.
Analyst downgrade ›
Maxim Group downgraded it to Hold from Buy on August 8, 2026.
Source: Analyst action, Maxim Group, August 8, 2026Analyst downgrade ›
Maxim Group downgraded it to Hold from Buy on August 7, 2026.
Source: Analyst action, Maxim Group, August 7, 2026
Earnings miss, but the stock rose ›
The August 6, 2026 report missed the EPS estimate by 14.29%, and the share price rose 16.83% in the first session after it.
Source: Earnings report, August 6, 2026
- The two closest levels to watch are the 20-day EMA at $28.31, just above the price, and the 52-week low at $23.56, just below it.
- With the 14-day RSI at 47.3, CELH is in the neutral zone, and the MACD line is negative. Readings above 70 or below 30 signal stretched momentum.
- The share price rose 16.83% in the first session after the August 6, 2026 report, and CELH has beaten estimates in 4 of the 6 reports in our data.
CELH is trading below its 50-day and 200-day moving averages ($29.32 and $34.89), and that is why the trend reads down. A move back above the 50-day would be the first sign of repair. The 20-day EMA at $28.31 is the closest level above the price.
CELH's next level below the price is its 52-week low of $23.56.
Technical indicators
Momentum and trend for CELH, from its daily closes.
As of October 27, 2026, with CELH at $28.00, its 14-day RSI is 47.3 (neutral territory), its 50-day simple moving average is $29.32 and its 200-day is $34.89.
Calculated by CleaRank on daily closes as of October 27, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26). How we calculate these
What CELH moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 27, 2026, CELH's 1-year correlation of daily returns is +0.23 with S&P 500 (SPY), +0.21 with Nasdaq 100 (QQQ), +0.15 with Bitcoin (BTC) and +0.10 with gold (XAU).
CELH price target and analyst forecast
The analysts' target range and how their ratings split.
Analysts checks
2/3Most analysts rate it a buy ›
18 of 24 analysts rate it a buy or strong buy, 6 a hold and 0 a sell.Median target above the price ›
The median 12-month target of $40.00 is 42.9% above the price.More buy ratings than three months ago ›
18 of 24 rate it a buy now, against 20 of 23 three months ago.
CELH Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 13, 2026 | TD Cowen | Maintains | Buy |
| Aug 10, 2026 | Stephens & Co. | Maintains | Overweight |
| Aug 8, 2026 | Maxim Group | Downgrade | Hold |
| Aug 7, 2026 | UBS | Maintains | Buy |
| Aug 7, 2026 | Citigroup | Maintains | Buy |
| Aug 7, 2026 | Maxim Group | Downgrade | Hold |
As of October 27, 2026, 24 Wall Street analysts cover CELH: 18 rate it a buy or strong buy, 6 a hold and 0 a sell or strong sell. Their 12-month price targets range from $26.00 to $64.00. The median CELH price target is $40.00, 42.9% above the price of $28.00.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
CELH trade plan: entry, stop loss and targets
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
CELH trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from CELH's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much CELH tends to move, against the market and on its own.
CELH price history and drawdowns
CELH's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 2.36% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 77.9%, from May 2024 to February 2025; the price is still 70.9% below that peak.Most 1-year holds ended higher ›
63% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $401,914, against $42,376 in the S&P 500 (SPY).
CELH Drawdowns & Recovery
As of October 27, 2026, CELH's worst peak-to-trough fall over the last 10 years with dividends reinvested was -77.9% (May 2024 to February 2025); it is still 70.9% below that peak, and 63% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into CELH in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: CELH beat the S&P 500 over this period: $401,914 against $42,376.
A $10,000 investment in CELH in October 2016 would be worth about $401,914 today with dividends reinvested, compared with about $42,376 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to CELH, and which have not.
Strongest month, May: an average of +15.32%, up in 7 of 10 years.
Weakest month, March: an average of -3.70%, up in 5 of 10 years.
This month, October: has averaged -0.22%, up in 5 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, CELH's strongest calendar month has been May (average +15.32%, up in 7 of 10 years) and its weakest March (average -3.70%, up in 5 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
CELH stock price prediction 2030
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in CELH, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 4-year Monte Carlo simulation, based on 10 years of price history, projects that a $10,000 investment in CELH today could grow to about $15,647 by 2030 in the base case, with a 90th-percentile outcome near $56,366 and a 10th-percentile outcome around $4,343. Projections are statistical simulations, not guarantees.
CELH Stock Price Prediction 2030: Simulated Scenarios
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $43.81 for CELH by 2030 in the base case, from $28.00 today (1.6x over 4 years). The 10th-percentile path ends near $12.16. These are outcomes of a Monte Carlo simulation run on CELH's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $16.50 | $31.32 | $59.44 | |
| 2028 | $14.15 | $35.02 | $86.68 | |
| 2029 | $12.91 | $39.17 | $119 | |
| 2030 | $12.16 | $43.81 | $158 |
Method: a lognormal simulation of CELH's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles. CELH is highly volatile, so its upside column reaches an extreme multiple; treat it as a statistical tail, not an expectation. How the simulation works
CELH insider trading
What the people running the company have bought and sold.
CELH insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Net insider selling: Insiders bought $3.2M on the open market and sold $51.3M.
As of October 27, 2026, CELH insiders reported 12 open-market sales worth $51.3M and 8 open-market purchases worth $3.2M over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | Damon Desantis
Director
|
Buy | 36.0K | $1.0M |
| Sep 15, 2026 | Hal Kravitz
Director
|
Buy | 12.0K | $336.0K |
| Sep 10, 2026 | John Erick Fieldly
Chief Executive Officer
|
Buy | 18.0K | $493.8K |
| Aug 7, 2026 | Fletcher F Previn
Director
|
Grant | 3.8K | $105.9K |
| May 22, 2026 | John Erick Fieldly
Chief Executive Officer
|
Buy | 8.5K | $248.8K |
| May 22, 2026 | Hal Kravitz
Director
|
Buy | 8.4K | $249.7K |
| May 21, 2026 | Eric Hanson
President
|
Buy | 7.5K | $217.8K |
| Mar 2, 2026 | Joyce Russell
Director
|
Sell | 2.9K | $147.8K |
| Mar 2, 2026 | Thi Tuyet Trinh Lam
Officer
|
Grant | 9.2K | - |
| Feb 27, 2026 | Nicholas Castaldo
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Damon Desantis
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | John Erick Fieldly
Chief Executive Officer
|
Grant | 42.0K | - |
| Feb 27, 2026 | Eric Hanson
President
|
Grant | 10.7K | - |
| Feb 27, 2026 | Hal Kravitz
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Jarrod Langhans
Chief Financial Officer
|
Grant | 15.0K | - |
| Feb 27, 2026 | Caroline S Levy
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Richard Stephen Mattessich
Officer
|
Grant | 8.8K | - |
| Feb 27, 2026 | Hans Mj Melotte
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Cheryl S Miller
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Joyce Russell
Director
|
Grant | 2.6K | - |
| Feb 27, 2026 | Paul H Storey
Officer
|
Grant | 8.8K | - |
| Dec 9, 2025 | John Erick Fieldly
Chief Executive Officer
|
Grant | 18.6K | - |
| Dec 9, 2025 | Tony Guilfoyle
Officer
|
Grant | 11.1K | - |
| Dec 9, 2025 | Eric Hanson
President
|
Grant | 11.1K | - |
| Dec 9, 2025 | Jarrod Langhans
Chief Financial Officer
|
Grant | 11.1K | - |
| Dec 9, 2025 | Richard Stephen Mattessich
Officer
|
Grant | 11.1K | - |
| Dec 9, 2025 | Paul H Storey
Officer
|
Grant | 11.1K | - |
| Nov 13, 2025 | Hal Kravitz
Director
|
Buy | 10.0K | $452.4K |
| Nov 12, 2025 | Eric Hanson
President
|
Buy | 4.6K | $200.2K |
| Oct 16, 2025 | Jarrod Langhans
Chief Financial Officer
|
Sell | 5.0K | $325.0K |
| Oct 10, 2025 | William H Milmoe
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 40.0K | $2.5M |
| Sep 3, 2025 | Paul H Storey
Officer
|
Sell | 7.5K | $457.0K |
| Aug 18, 2025 | Jarrod Langhans
Chief Financial Officer
|
Sell | 5.0K | $300.0K |
| Aug 7, 2025 | John Erick Fieldly
Chief Executive Officer
|
Sell | 143.2K | $7.3M |
| Aug 7, 2025 | Jarrod Langhans
Chief Financial Officer
|
Sell | 5.0K | $255.9K |
| Jul 31, 2025 | Dean Desantis
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 100.0K | $4.8M |
| Jul 29, 2025 | Dean Desantis
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 200.0K | $9.5M |
| Jul 1, 2025 | William H Milmoe
Beneficial Owner of more than 10% of a Class of Security
|
Sell | 300.0K | $14.2M |
| Jun 24, 2025 | John Erick Fieldly
Chief Executive Officer
|
Sell | 130.8K | $5.9M |
| Jun 10, 2025 | John Erick Fieldly
Chief Executive Officer
|
Sell | 132.2K | $5.7M |
| May 30, 2025 | Eric Hanson
President
|
Grant | 46.9K | - |
Source: TwelveData, from SEC Form 4 filings
CELH stock forecast: questions people ask
Answered from the figures on this page, as of October 27, 2026.